The AFP isoform L3 percentage was 34.8%, and the GALAD score, which determines risk of HCC based on patient sex, age, and serum levels of AFP, AFP-L3, and des-gamma-carboxy prothrombin (DCP), was ≥2.57. This evidence concerns the gene AFP and hepatocellular carcinoma.